St. Jude Medical
This article was originally published in The Gray Sheet
Executive Summary
PMA supplements are submitted to FDA for the Angstrom MD and Contour MD implantable cardioverter defibrillators, the company reports June 5. Launched in Europe earlier in the year, the Angstrom MD and Contour MD incorporate a proprietary Morphology Discrimination algorithm to distinguish between life-threatening ventricular tachyarrhythmias and less serious atrial tachyarrythmias, which reduces unnecessary shocks